文献速递心外重症与机械循环支持

左心室辅助装置患者并发噬血细胞性淋巴组织细胞增多症一例

Haemophagocytic lymphohistiocytosis in a patient with left ventricular assist device.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

本文报告一例53岁男性左心室辅助装置(LVAD)患者,因驱动线感染就诊后出现全血细胞减少,诊断为噬血细胞现象。立即给予静脉注射免疫球蛋白和甲泼尼龙治疗后血细胞计数恢复正常,患者重新具备心脏移植资格。作者提示该罕见并发症若未及时发现可致命。

要点

  • LVAD患者出现全血细胞减少需警惕噬血细胞现象
  • 驱动线感染后应监测血细胞计数变化
  • 早期静脉免疫球蛋白联合甲泼尼龙治疗可逆转血细胞减少

核心结论

  • LVAD患者可罕见发生噬血细胞现象,及时识别并给予静脉免疫球蛋白和甲泼尼龙治疗可使血细胞计数恢复并重新获得心脏移植资格。

研究设计与样本

  • 单例病例报告:53岁男性LVAD患者,因驱动线感染就诊,随后出现全血细胞减少并诊断为噬血细胞现象。

主要发现

  • 患者在接受静脉注射免疫球蛋白和甲泼尼龙治疗后血细胞计数恢复正常水平,并重新符合心脏移植条件。

临床怎么用

  • LVAD患者出现驱动线感染并伴全血细胞减少时,应将噬血细胞现象纳入鉴别诊断并及时启动免疫调节治疗。

局限性

  • 为单例病例报告,证据级别低,不能推广至所有LVAD患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Left ventricular assist devices provide circulatory support to heart failure patients while awaiting a suitable donor heart. However, with their increased duration of therapy, complications are seen frequently. Although coagulation disorders (bleeding and thrombosis) are the most common complications, infection is also a major complication associated with significant morbidity. We report a case of a 53-year-old male with a left ventricular assist device who presented with driveline infection. He subsequently developed pancytopenia and was diagnosed with haemophagocytosis. Immediate treatment with intravenous immunoglobulin and methylprednisolone was started. His blood cell count returned to normal levels and the patient became eligible for heart transplantation again. Our case represents the rare occurrence of haemophagocytosis in a patient, which, if unnoticed, could lead to fatal consequences.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ergi DG, Dorken Gallastegi A, Arslan E, et al. Haemophagocytic lymphohistiocytosis in a patient with left ventricular assist device. Eur J Cardiothorac Surg. 2021. PMID: 33659984. doi:10.1093/ejcts/ezab102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。